Search Results

There are 78153 results for: content related to: Frontmatter

  1. Selection of Optimal Adjuvants and Product Factors that Affect Vaccine Immunogenicity

    Development of Vaccines: From Discovery to Clinical Testing

    Wei Wang, Manmohan Singh, Pages: 327–383, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch13

  2. DNA Vaccines for Infectious Diesase

    Development of Vaccines: From Discovery to Clinical Testing

    Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava, Pages: 215–242, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch8

  3. Tools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope-Driven Vaccines

    Development of Vaccines: From Discovery to Clinical Testing

    Anne S. De Groot, Matthew Ardito, Ryan Tassone, Paul Knopf, Leonard Moise, William Martin, Pages: 65–94, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch3

  4. Lyophilization and Stabilization of Vaccines

    Development of Vaccines: From Discovery to Clinical Testing

    James Chesko, Chris Fox, Tim Dutill, Thomas Vedvick, Steve Reed, Pages: 385–397, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch14

  5. Design and Development of Recombinant Vaccines with Viral Properties

    Development of Vaccines: From Discovery to Clinical Testing

    Gerd Lipowsky, Martin F. Bachmann, Pages: 19–63, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch2

  6. Designing Immunogens for Vaccine Development in Reference to HIV

    Development of Vaccines: From Discovery to Clinical Testing

    Aemro Kassa, Zohar Biron-Sorek, Pampi Sarkar, Indresh K. Srivastava, Pages: 141–184, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch6

  7. Biophysical Characterization of Protein Antigens within Vaccine Formulations

    Development of Vaccines: From Discovery to Clinical Testing

    Padma Malyala, Derek O'Hagan, Manmohan Singh, Pages: 293–303, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch11

  8. You have free access to this content
    Frontmatter

    Vaccine Adjuvants and Delivery Systems

    Manmohan Singh, Pages: i–x, 2006

    Published Online : 2 NOV 2006, DOI: 10.1002/9780470134931.fmatter

  9. Pharmacoepidemiologic Studies of Vaccine Safety

    Pharmacoepidemiology, Fifth Edition

    Robert T. Chen, Jason M. Glanz, Claudia Vellozzi, Pages: 423–468, 2012

    Published Online : 3 JAN 2012, DOI: 10.1002/9781119959946.ch26

  10. Expression and Purification of Recombinant Proteins for Vaccine Applications

    Development of Vaccines: From Discovery to Clinical Testing

    Carlo Zambonelli, Deeann Martinez-Guzmann, Indresh K. Srivastava, Pages: 185–213, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch7

  11. Spectroscopy of Vaccines

    Development of Vaccines: From Discovery to Clinical Testing

    C. Russell Middaugh, Sangeeta B. Joshi, Pages: 261–292, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch10

  12. Preparation of highly concentrated influenza vaccine for use in novel delivery approaches

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 866–875, Sushma Kommareddy, Amanda Bonificio, Simona Gallorini, Barbara Baudner, Manmohan Singh and Derek O'Hagan

    Article first published online : 9 JAN 2013, DOI: 10.1002/jps.23444

  13. Pure Contagion and Investors’ Shifting Risk Appetite: Analytical Issues and Empirical Evidence

    International Finance

    Volume 5, Issue 3, November 2002, Pages: 401–436, Manmohan S. Kumar and Avinash Persaud

    Article first published online : 30 MAY 2003, DOI: 10.1111/1468-2362.00102

  14. A two-stage strategy for sterilization of poly(lactide-co-glycolide) particles by γ-irradiation does not impair their potency for vaccine delivery

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 646–654, Siddhartha Jain, Padma Malyala, Michele Pallaoro, Marzia Giuliani, Holger Petersen, Derek T. O'hagan and Manmohan Singh

    Article first published online : 27 JUL 2010, DOI: 10.1002/jps.22306

  15. From the Lab to the Clinic: Filing a Phase I IND for an Investigational Vaccine

    Development of Vaccines: From Discovery to Clinical Testing

    Manmohan Singh, Indresh K. Srivastava, Pages: 437–450, 2011

    Published Online : 6 JUN 2011, DOI: 10.1002/9781118023648.ch17

  16. MF59: A Safe and Potent Oil-in-Water Emulsion Adjuvant

    Vaccine Adjuvants and Delivery Systems

    Derek T. O'Hagan, Manmohan Singh, Pages: 115–129, 2006

    Published Online : 2 NOV 2006, DOI: 10.1002/9780470134931.ch5

  17. Managing Demand Risk in Tactical Supply Chain Planning for a Global Consumer Electronics Company

    Production and Operations Management

    Volume 14, Issue 1, March 2005, Pages: 69–79, ManMohan S. Sodhi

    Article first published online : 5 JAN 2009, DOI: 10.1111/j.1937-5956.2005.tb00010.x

  18. The Development of Self-Emulsifying Oil-in-Water Emulsion Adjuvant and an Evaluation of the Impact of Droplet Size on Performance

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 4, April 2015, Pages: 1352–1361, Ruchi R. Shah, Stephanie Dodd, Mary Schaefer, Mildred Ugozzoli, Manmohan Singh, Gillis R. Otten, Mansoor M. Amiji, Derek T. O'Hagan and Luis A. Brito

    Article first published online : 19 JAN 2015, DOI: 10.1002/jps.24337

  19. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 3, March 2012, Pages: 1021–1027, Sushma Kommareddy, Barbara C. Baudner, Seajin Oh, Sung-yun Kwon, Manmohan Singh and Derek T. O'hagan

    Article first published online : 20 DEC 2011, DOI: 10.1002/jps.23019

  20. You have free access to this content
    Abstracts - Monday 23rd July 2001

    Scandinavian Journal of Immunology

    Volume 54, Issue s1, July/August 2001, Page: 1,

    Article first published online : 11 MAR 2002, DOI: 10.1046/j.1365-3083.2001.0540s1001.x